BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Cystinosis readouts · AssetMemo
X-WR-CALDESC:Upcoming phase 1/2 and later readouts in Cystinosis\, from Cli
 nicalTrials.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06910813-11248@assetmemo.bio
DTSTAMP:20261121T004105Z
DTSTART;VALUE=DATE:20310528
DTEND;VALUE=DATE:20310529
SUMMARY:DFT383: Phase 1/2 readout est. (NCT06910813)
DESCRIPTION:DFT383\, phase 1/2\, Cystinosis.\nStudy: DFT383 in Pediatric Pa
 rticipants With Nephropathic Cystinosis\nEstimated primary completion: 28 
 May 2031. This is a ClinicalTrials.gov estimate\, not a confirmed readout 
 date\, and it can move.\nDrug page: https://assetmemo.bio/drug/dft383#upco
 ming-events\nRegistry record: https://clinicaltrials.gov/study/NCT06910813
URL:https://assetmemo.bio/drug/dft383#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
